Bioanalysis during pregnancy: Recent advances and novel sampling strategies

Bioanalysis

Volumn 6, Issue 23, 2014, Pages 3133-3153

  Concheiro Guisan, Ana ^a   Concheiro, Marta ^b  

^a UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPRAZOLAM; ARACHIDONIC ACID; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; CANNABIS; CLONAZEPAM; CLONIDINE; COCAINE; DIAMORPHINE; DIAZEPAM; ETHYL GLUCURONIDE; FATTY ACID ESTER; HYDROCODONE; HYDROMORPHONE; LAURIC ACID; LINOLEIC ACID; LINOLENIC ACID; LORAZEPAM; METHADONE; METHAMPHETAMINE; MIDAZOLAM; MORPHINE; MYRISTIC ACID; NICOTINE; NORDAZEPAM; OXAZEPAM; PALMITOLEIC ACID; TEMAZEPAM;

ANALYTIC METHOD; BEHAVIOR DISORDER; BLOOD ANALYSIS; CALORIC INTAKE; COGNITIVE DEFECT; CONGENITAL MALFORMATION; CORRELATION ANALYSIS; DEEP VEIN THROMBOSIS; DRUG ABUSE; DRUG DETERMINATION; ELECTROSPRAY MASS SPECTROMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FETAL ALCOHOL SYNDROME; HAIR ANALYSIS; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MASS FRAGMENTOGRAPHY; MATERNAL HYPERTENSION; MEASUREMENT ACCURACY; MECONIUM; OPIATE ADDICTION; PLACENTA; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; QUALITY CONTROL; REVIEW; SOLID PHASE MICROEXTRACTION; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; SWEAT; SYSTEMATIC REVIEW; TANDEM MASS SPECTROMETRY; TERATOGENICITY; TIME OF FLIGHT MASS SPECTROMETRY; TOBACCO; UMBILICAL CORD; URINALYSIS; WITHDRAWAL SYNDROME; ADVERSE EFFECTS; DIAGNOSTIC PROCEDURE; ENVIRONMENTAL EXPOSURE; FEMALE; LABORATORY DIAGNOSIS; PROCEDURES;

CLINICAL LABORATORY TECHNIQUES; FEMALE; HUMANS; MATERNAL EXPOSURE; PREGNANCY; SPECIMEN HANDLING;

EID: 84919784029     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.14.278     Document Type: Review

References (105)

1. White SM. The effect of controlled drugs on the unborn child and fetus. J. Cin. Forensic Med. 8, 129-139 (2001
2. Sithisarn T, Granger DT, Bada HS. Consequences of prenatal substance use. Int. J. Adolesc. Med. Health 24, 105-112 (2012
3. Finnegan LP. Women, pregnancy and methadone. Heroin Add. Rel. Cin. Probl. 2, 1-8 (2000
4. Huestis MA, Choo RE. Drug abuse's smallest victims: In utero drug exposure. Forensic Sci. Int. 128, 20-30 (2002
5. Wilcox AJ, Weinberg CR, Baird DD. Risk factors for early pregnancy loss. Epidemiology 1, 382-385 (1990
6. Cruz A, Bouzas CA, Concheiro M, et al. Drogas y Teratogenia. Adicciones 18(1), 1-18 (2006
7. Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. Substance Abuse and Mental Health Services Administration, MD, USA (2013
8. Observatorio Espanol de la Droga y las Toxicomanias. Informe 2011. Situacion y tendencias de los problemas de la drogas en Espana. www.pnsd.msssi.gob.es.
9. Ostrea EM Jr, Knapp DK, Tannenbaum L, et al. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis. J. Pediatr. 138, 344-348 (2001
10. Friguls B, Joya X, Garica-Serra J, et al. Assessment of exposure to drugs of abuse during pregnancy by hair analysis in a Mediterranean island. Addiction 107, 1471-1479 (2012
11. Gray T, Huestis M. Bioanalytical procedures for monitoring in utero drug exposure. Anal. Bioanal. Chem. 388, 1455-1465 (2007
12. Lozano J, Garcia-Algar O, Vall O, et al. Biological matrices for the evaluation of in utero exposure to drugs of abuse. Ther. Drug Monit. 29, 711-734 (2007
13. Gallardo E, Queiroz JA. The role of alternative specimens in toxicological analysis. Biomed. Chromatogr. 22, 795-821 (2008
14. Plotka J, Narkowicz S, Polkowska Z, et al. Effects of addictive substances during pregnancy and infancy and their analysis in biological materials. In: Reviews of Environmental Contamination and Toxicology, Volume 227. Whitacre DM (Ed.). Springer International Publishing, Switzerland, 55-77 (2014
15. Ungerer M, Knezovich J, Ramsay M. In utero alcohol exposure, epigenetic changes, and their consequences. Alcohol Res. 35(1), 37-46 (2013
16. Behnke M, Smith VC. Comitee on substance abuse and Comitte on Fetus and Newborn. Prenatal substance abuse: Short and long-Term effects on the exposed fetus. Pediatrics 131(3), e1009-10024 (2014
17. Clave S, Joya X, Salat-Batlle J, et al. Ethanol cytotoxic effect on trophoblast cells. Toxicol. Lett. 225(2), 216-221 (2014
18. Kocherlakota P. Neonatal abstinence syndrome. Pediatrics 134, e547 (2014
19. Stanhope TJ, Gill LA, Rose C. Chronic opioid use during pregnancy: Maternal and fetal implications. Clin. Perinatol. 40(3), 509-524 (2013
20. Cleary BJ, Donnelly J, Strawbridge J, et al. Methadone dose and neonatal abstinence syndrome-systematic review and meta-Analysis. Addiction 105(12), 2071-2084 (2010
21. Reddy AM, Harper RG, Stern G. Observations on heroin and methadone withdrawal in the newborn. Pediatrics 48(3), 353-358 (1971
22. Kieviet N, Dolman KM, Honig A. The use of psychotropic medication During pregnancy: How about the newborn? Neuropsychiatr. Dis. Treat. 9, 1257-1266 (2013
23. Mactier H. Neonatal and longer term management following substance misuse in pregnancy. Early Hum. Dev. 89(11), 887-892 (2013
24. Jones HE, Kaltenbach K, Heil SH, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N. Engl. J. Med. 363(24), 2320-2331 (2010
25. Diaz SD, Smith LM, Lagasse LL, et al. Effects of prenatal methamphetamine exposure on behavioral and cognitive findings at 7.5 years of age. J. Pediatr. 164(6), 1333-1338 (2014
26. Buckingham-Howes S, Berger SS, Scaletti LA, Black MM. Systematic review of prenatal cocaine exposure and adolescent development. Pediatrics 131(6), e1917-e1936 (2013
27. Ackerman JP, Riggins T, Black MM. A review of the effects of prenatal cocaine exposure among school-Aged children. Pediatrics 125(3), 554-565 (2010
28. Minnes S, Singer L, Min MO Effects of prenatal cocaine/polydrug exposure on substance use by age 15. Drug Alcohol Depend. 134, 201-210 (2014
29. Muller KU, Menningen E, Ripke S, et al. Altered reward processing in adolescents with prenatal exposure to maternal cigarette smoking. JAMA Psychiatry 70(8), 847-856 (2013
30. Vassoler FM, Byrnes EM, Pierce RC. The impact of exposure to addictive drugs on future generations: Physiological and behavioral effects. Neuropharmacology 76, 269-275 (2014
31. Child Welfare Information Gateway. U.S. Department of Health and Human Services. (2012
32. Concheiro M, Gonzalez-Colmenero E, Lendoiro E, et al. Alternative matrices for cocaine, heroin, and methadone in utero drug exposure detection. Ther. Drug Monit. 35(4), 502-509 (2013
33. Kacinko SL, Jones HE, Johnson RE, Choo RE, et al. Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes. Cin. Pharmacol. Ther. 84, 604-12 (2008
34. Casanova OQ, Lombardero N, Behnke M, et al. Detection of cocaine exposure in the neonate. Analyses of urine, meconium, and amniotic fluid from mothers and infants exposed to cocaine. Arch. Pathol. Lab. Med. 118, 988-93 (1994
35. Moller M, Karaskov T, Koren G. Opioid detection in maternal and neonatal hair and meconium: Characterization of an at-risk population and implications to fetal toxicology. Ther. Drug Monit. 32, 318-323 (2010
36. Garcia-Boumissen , Rokach B, Karaskov T, et al. Methamphetamine detection in maternal and neonatal hair: Implication for fetal safety. Arch. Dis. Child Fetal Neonatal Ed. 92, 351-355 (2007
37. de Castro A, Jones HE, Johnson RE, et al. Methadone, cocaine, opiates, and metabolites disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes. Ther. Drug Monit. 33, 443-452 (2011
38. Concheiro M, Jones HE, Johnson RE, et al. Umbilical cord monitoring of in utero drug exposure to buprenorphine and correlation with maternal dose and neonatal outcomes. J. Anal. Toxicol. 34, 498-505 (2010
39. Montgomery D, Plate C, Alder SC, et al. Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium. J. Perinatol. 26, 11-14 (2006
40. Moore CM, Brown S, Negrusz A, et al. Determination of cocaine and its major metabolite, benzoylecgonine, in amniotic fluid, umbilical cord blood, umbilical cord tissue, and neonatal urine: A case study. J. Anal. Toxicol. 17(1), 62 (1993
41. Winecker RE, Goldberger BA, Tebbett I, et al. Detection of cocaine and its metabolites in amniotic fluid and umbilical cord tissue. J. Anal. Toxicol. 21, 97-104 (1997
42. de Castro A, Jones HE, Johnson RE, et al. Maternal methadone dose, placental methadone concentrations, and neonatal outcomes. Clin. Chem. 57, 449-458 (2011
43. Concheiro M, Jones HE, Johnson RE, et al. Maternal buprenorphine dose, placenta buprenorphine, and metabolite concentrations and neonatal outcomes. Ther. Drug Monit. 32, 206-215 (2010
44. Falcon M, Pichini S, Joya J, et al. Maternal hair testing for the assessment of fetal exposure to drug of abuse during early pregnancy: Comparison with testing in placental and fetal remains. Forensic Sci. Int. 218, 92-96 (2012
45. Garcia-Algar O, Lopez-Vilchez MA, Martin I, et al. Confirmation of gestational exposure to alprazolam by analysis of biological matrices in a newborn with neonatal sepsis. Cin. Toxicol. 45, 295-298 (2007
46. Martin I, Lopez-Vilchez MA, Mur A, et al. Neonatal withdrawal syndrome after chronic maternal drinking of mate. Ther. Drug Monit. 29, 127-129 (2007
47. Garcia-Algar O, Vall O, Alameda F, et al. Prenatal exposure to arecoline (areca nut alkaloid) and birth outcomes. Arch. Dis. Child Fetal Neonatal Ed. 90, F276-F277 (2005
48. US Department of Health and Human Services, Food and Drug Administration. Mass Spectrometry for Confirmation of the Identity of Animal Drug Residues. (2003
49. European Union Decision 2002/657/EC (17/8/2002), Off. J. Eur. Commun. 221, 8-36 (2002
50. Scientific Working Group for Forensic Toxicology (SWGTOX). Standard practices for method validation in forensic toxicology. J. Anal. Toxicol. 37, 452-474 (2013
51. Bakdash A, Burger P, Goecke TW, et al. Quantification of fatty acid ethyl esters (FAEE) and ethyl glucuronide (EtG in meconium from newborns for detection of alcohol abuse in a maternal health evaluation study. Anal. Bioanal. Chem. 396, 2469-2477 (2010
52. Hastedt M, Krumbiegel F, Gapert R, et al. Fatty acid ethyl esters (FAEEs) as markers for alcohol in meconium: Method validation and implementation of a screening program for prenatal drug exposure. Forensic Sci. Med. Pathol. 9, 287-295 (2013
53. Himes SK, Concheiro M, Scheidweiler KB, et al. Validation of a novel method to identify in utero ethanol exposure: Simultaneous meconium extraction of fatty acid ethyl esters, ethyl glucuronide, and ethyl sulfate followed by LC-MS/MS quantification. Anal. Bioanal. Chem. 406(7), 1945-1955 (2014
54. Cabarcos P, Tabernero MJ, Alvarez I, et al. A new method for quantifying prenatal exposure to ethanol by microwave-Assisted extraction (MAE) of meconium followed by gas chromatography-mass spectrometry (GC-MS). Anal. Bioanal. Chem. 404, 147-155 (2012
55. Hutson JR, Rao C, Fulga N, et al. An improved method for rapidly quantifying fatty acid ethyl esters in meconium suitable for prenatal alcohol screening. Alcohol 45, 193-199 (2011
56. Tarcomnicu I, van Nuijs ALN, Aerts K, et al. Ethyl glucuronide determination in meconium and hair by hydrophilic interaction liquid chromatography-Tandem mass spectrometry. Forensic Sci. Int. 196, 121-127 (2010
57. Roehsig M, Mendes Louzada de Paula D, Moura S, et al. Determination of eight fatyy acid ethyl esters in meconium samples by headspace solid-phase microextraction and gas chromatography-mass spectrometry. J. Sep. Sci. 33, 2115-2122 (2010
58. Kwak HS, Kang YS, Han KO, et al. Quantitation of fatty acid ethyl esters in human meconium by an improved liquid chromatography/tandem mass spectrometry. J. Chromatogr. B 878, 1871-1874 (2010
59. Bakdash A, Burger P, Goecke TW, et al. Quantification of fatty acid ethyl esters (FAEE) and ethyl glucuronide (EtG) in meconium from newborns for detection of alcohol abuse in a maternal health evaluation study. Anal. Bioanal. Chem. 396, 2469-2477 (2010
60. Morini L, Marchei E, Pellegrini M, et al. Liquid chromatography with tandem mass spectrometric detection for the measurement of ethyl glucuronide and ethyl sulfate in meconium: New biomarkers of gestational ethanol exposure. Ther. Drug Monit. 30, 725-732 (2008
61. Gray TR, Barnes AJ, Huestis MA. Effect of hydrolysis on identifying prenatal cannabis exposure. Anal. Bioanal. Chem. 397, 2335-2347 (2010
62. Marin SJ, Coles R, Urry FM, et al. Confirmation of cannabinoids in meconium using two-dimensional gas chromatography with mass spectrometry detection. J. Chromatogr. B 858, 59-64 (2007
63. Marin SJ, Coles R, Merrell M, et al. Quantitation of benzodiazepines in urine, serum, plasma, and meconium by LC-MS-MS. J. Anal. Toxicol. 32, 491-498 (2008
64. Kelly T, Gray TR, Huestis M. Development and validation of a liquid-chromatography-Atmospheric pressure chemical ionization-Tandem mass spectrometry method of simultaneous analysis of 10 amphetamine-, methamphetamine- And 3, 4-methylenedioxymethamphetamine-related (MDMA) analytes in human meconium. J. Chromatogr. B 867, 194-204 (2008
65. Gunn JA, Sweeney B, Dahn T, et al. Simultaneous quantification of amphetamine and methamphetamine in meconium using ISOLUTER HM-N-supported liquid extraction columns and GC-MS. J. Anal. Toxicol. 32, 485-490 (2008
66. Kacinko SL, Shakleya DM, Huestis MA. Validation and application of a method for the determination of buprenorphine, norbuprenorphine, and their glucuronide conjugates in human meconium. Anal. Chem. 80, 246-252 (2008
67. de Carvalho Mantovani C, Bittar Lima M, Rodrigues de Oliveira CD, et al. Development and practical application of accelerated solvent extraction for the isolation of cocaine/crack biomarkers in meconium samples. J. Chromatogr. B 957, 14-23 (2014
68. Coles R, Kushnir MM, Nelson GJ, et al. Simultaneous determination of codeine, morphine, hydrocodone, hydromorphone, oxycodone, and 6-Acetylmorphine in urine, serum, plasma, whole blood, and meconium by LC-MS/MS. J. Anal. Toxicol. 31, 1-14 (2007
69. Marin SJ, Christensen RD, Baer VL, et al. Nicotine and metabolites in paired umbilical cord tissue and meconium specimens. Ther. Drug Monit 33, 80-85 (2011
70. Gray TR, Shakleya DM, Huestis MA. Quantification of nicotine, cotinine, trans-3'-hydroxycotinine, nornicotine and norcotinine in human meconium by liquid chromatography/tandem mass spectrometry. J. Chromatogr. B 863, 107-114 (2008
71. Mozaner Bordin DC, Alves MNR, Cabrices OG, et al. A rapid assay for the simultaneous determination of nicotine, cocaine and metabolites in meconium using disposable pipette extraction and gas chromatographymass spectrometry (GC-MS). J. Anal. Toxicol. 38, 31-38 (2014
72. Lopez P, Bermejo AM, Tabernero MJ, et al. Cocaine and opiates use in pregnancy: Detection of drugs in neonatal meconium and urine. J. Anal. Toxicol. 33, 351-355 (2009
73. Gray TR, Shakleya DM, Huestis MA. A liquid chromatography tandem mass spectrometry method for the simultaneous quantification of 20 drugs of abuse and metabolites in human meconium. Anal. Bioanal. Chem. 393, 1977-1990 (2009
74. Pichini S, Morini L, Pacifici R, et al. Development of a new immunoassay for the detection of ethyl glucuronide (EtG) in meconium: Validation with authentic specimens analyzed using LC-MS/MS. Preliminary results. Clin. Chem. Lab. Med. doi: 10.1515/cclm-2013-1087 (2014) (Epub ahead of print
75. Marin SJ, Merrell M, McMillin GA. Drugs of abuse detection in meconium: A comparison between ELISA and biochip microarray. J. Anal. Toxicol. 35, 40-45 (2011
76. Marin SJ, Keith L, Merrell M, et al. Comparison of drugs of abuse detection in meconium by EMITRII and ELISA. J. Anal. Toxicol. 33, 148-154 (2009
77. Ristimaa J, Gergov M, Pelander A, et al. Broad-spectrum drug screening of meconium by liquid chromatography with tandem mass spectrometry and time-of-flight mass spectrometry. Anal. Bioanal. Chem. 398, 925-935 (2010
78. Nanovskaya T, Deshmukh S, Brooks M, et al. Transplacental transfer and metabolism of buprenorphine. J. Pharmacol. Exp. Ther. 300(1), 26-33 (2002
79. Syme MR, Paxton JW, Keelan JA. Drug transfer and metabolism by the human Placenta. Clin. Pharmacokinet 43(8), 487-514 (2004
80. de Castro A, Diaz A, Pineiro B, et al. Simultaneous determination of opiates, methadone, amphetamines, cocaine, and metabolites in human placenta and umbilical cord by LC-MS/MS. Anal. Bioanal. Chem. 405(12), 4295-4305 (2013
81. Matlow JN, Aleksa K, Lubetsky A, et al. The detection and quantification of ethyl glucuronide in placental tissue perfusate by headspace solid-phase microextraction coupled with gas chromatography-mass spectrometry. J Popul Ther. Cin. Pharmacol 19(3), e473-e482 (2012
82. Morini L, Falcon M, Pichini S, et al. Ethyl-glucuronide and ethyl-sulfate in placental and fetal tissues by liquid chromatography couple with tandem mass spectrometry. Anal. Biochem. 418, 30-36 (2011
83. Concheiro-Guisan M, Shakleya DM, Huestis MA. Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry. Anal. Bioanal. Chem. 394, 513-522 (2009
84. Joya X, Pujadas M, Falcon M, et al. Gas chromatographymass spectrometry assay for the simultaneous quantification of drugs of abuse in human placenta at 12th week of gestation. Forensic Sci. Int 196, 38-42 (2010
85. de Castro A, Concheiro M, Shakleya D, et al. Simultaneous quantification of methadone, cocaine, opiates, and metabolites in human placenta by liquid chromatographymass spectrometry. J. Anal. Toxicol. 33, 243-252 (2009
86. Kilman H. Umbilical cord. In: Encyclopedia of Reproduction, Volume 4. Knobil E, Neil J (Eds). Academic Press, CA, USA, 915-923 (1999
87. Concheiro M, Shakleya D, Huestis MA. Simultaneous quantificatification of buprenorphine, norbuprenorphine, buprenorphine-glucuronide and norbuprenorphineglucuronide in human umbilical cord by liquid chromatography tandem mass spectrometry. Forensic Sci. Int 188, 144-151 (2009
88. Jones J, Rios R, Jones M, et al. Determination of amphetamine and methamphetamine in umbilical cord using liquid chromatography-Tandem mass spectrometry. J. Chromatogr. B 877, 3701-3706 (2009
89. De Castro A, Concheiro M, Shakleya DM, et al. Development and validation of a liquid chromatography mass spectrometry assay for the simultaneous quantification of methadone, cocaine, opiates and metabolites in human umbilical cord. J. Chromatogr. B 877, 3065-3071 (2009
90. Chittama A, Marin SJ, Williams JA, et al. Detection of in utero marijuana exposure by GC-MS, ultra-sensitive ELISA and LC-TOF-MS using umbilical cord tissue. J. Anal. Toxicol. 37, 391-394 (2013
91. Marin SJ, Metcalf A, Krasowski MD, et al. Detection of neonatal drug exposure using umbilical cord tissue and liquid chromatography time-of-flight mass spectrometry. Ther. Drug Monit 36, 119-124 (2014
92. Pragst F, Balikova MA. State of the art in hair analysis for detection of drug and alcohol abuse. Clin. Chim. Acta 370, 17-49 (2006
93. Lendoiro E, Gonzalez-Colmenero E, Concheiro-Guisan A, et al. Maternal hair analysis for the detection of illicit drugs, medicines, and alcohol exposure during pregnancy. Ther. Drug Monit 35, 296-304 (2013
94. Joya X, Gomez-Culebras M, Callejon A, et al. Cocaine use during pregnancy assessed by hair analysis in a Canry Islands cohort. BMC Pregnancy Childbirth 12, 2-8 (2012
95. Vincenti M, Salomone A, Gerace E, et al. Role of LC-MS/MS in hair testing for the determination of common Drugs of abuse and other psychoactive drugs. Bioanalysis 5(15), 1919-1938 (2013
96. Crunelle CL, Yegles M, van Nuijs ALN, et al. Hair ethyl glucuronide levels as a marker for alchol use and abuse: A review of the current state of art. Drug Alcohol Depend. 134, 1-11 (2014
97. Society of Hair Testing, Statement 2011. (2014
98. Favretto D, Stocchero G, Vogliardi S, et al. Neonatal hair analysis by liquid chromatography-high resolution mass spectrometry to reveal gestational exposure to venlafaxine. Ther. Drug Monit. 32, 30-39 (2010
99. Frison G, Favretto D, Vogliardi S, et al. Quantification of citalopram or escitalopram and their demethylated metabolites in neonatal hair samples by liquid chromatography-Tandem mass spectrometry. Ther. Drug Monit. 30, 467-473 (2008
100. Goodwin RS, Wilkins DG, Averin O, et al. Buprenorphine and norbuprenorphine in hair of pregnant women and their infants after controlled buprenorphine administration. Clin. Chem. 53(12), 2136-2143 (2007
101. Su PH, Chank YZ, Yang C, et al. Perinatal effects of combined use of heroin, methadone, and amphetamine during pregnancy and quantitative measurement of metabolites in hair. Pediatr. Neonatol. 53, 112-117 (2012
102. Aleksa K, Walasek P, Fulga N, et al. Simultaneous detection of seventeen Drugs of abuse and metabolites in hair using solid phase micro extraction (SPME) with GC/MS. Forensic Sci. Int. 218, 31-36 (2012
103. Kohlet E, Avenarius S, Rabsilber A, et al. Nicotine and its metabolites in amniotic fluid at birth - Assessment of prenatal tobacco smoke exposure. Hum. Exp. Toxicol. 29(5), 385-391 (2010
104. Engelhart DA, Jenkins AJ. Detection of cocaine analytes and opiates in nails from postmortem cases. J. Anal. Toxicol. 26, 489-492 (2002
105. Mari F, Politi L, Bertol E. Nails of newborns in monitoring drug exposure during pregnancy. Forensic Sci. Int. 179, 176-180 (2008